Compare Bitdeer Technologies Group (BTDR) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bitdeer Technologies Group vs Johnson & Johnson — how do they compare? Bitdeer Technologies Group trades at $8.97 (market cap $2.36B), while Johnson & Johnson trades at $260.7 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 265.3× Bitdeer Technologies Group's market cap, and Johnson & Johnson pays a 2.06% dividend while Bitdeer Technologies Group pays none. Which is the better fit depends on your goals.
| BTDR | JNJ | |
|---|---|---|
Market Cap | $2.36B | $626.09B |
Sector | Technology | Health |
52-Week High | $25.90 | $267.24 |
52-Week Low | $7.28 | $172.78 |
Enterprise Value | $3.85B | $654.37B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BTDR trades at $9.18, up 5.58% today but facing bearish technical signals with 13 of 13 moving averages indicating sell signals. The company reported Q2 2026 revenue growth but missed EPS expectations for the fourth consecutive quarter with a loss of $0.37 per share. Recent developments include a significant $4.7 billion AI data center deal announced August 4, 2026, signaling strategic expansion beyond Bitcoin mining into AI infrastructure.
Despite analyst optimism with 82% buy ratings and a $22.43 consensus price target, fundamental challenges persist including negative net income margin (-28.14%) and cash flow concerns. The stock offers substantial upside potential if AI initiatives succeed but faces execution risk amid volatile cryptocurrency markets and competitive pressures in the infrastructure sector.
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bitdeer Technologies Group
Bitdeer is a world-leading technology company for blockchain and high-performance computing. It provides comprehensive digital asset mining solutions, including cloud mining, hosting, and data center management.
Read more on BTDR →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
